Cargando…

Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19

Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroq...

Descripción completa

Detalles Bibliográficos
Autores principales: Saqrane, S., El Mhammedi, M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171523/
https://www.ncbi.nlm.nih.gov/pubmed/32322402
http://dx.doi.org/10.1016/j.nmni.2020.100680
_version_ 1783524088433606656
author Saqrane, S.
El Mhammedi, M.A.
author_facet Saqrane, S.
El Mhammedi, M.A.
author_sort Saqrane, S.
collection PubMed
description Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses.
format Online
Article
Text
id pubmed-7171523
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-71715232020-04-22 Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19 Saqrane, S. El Mhammedi, M.A. New Microbes New Infect Mini-Review Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses. Elsevier 2020-04-14 /pmc/articles/PMC7171523/ /pubmed/32322402 http://dx.doi.org/10.1016/j.nmni.2020.100680 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Review
Saqrane, S.
El Mhammedi, M.A.
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
title Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
title_full Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
title_fullStr Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
title_full_unstemmed Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
title_short Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19
title_sort review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of covid-19
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171523/
https://www.ncbi.nlm.nih.gov/pubmed/32322402
http://dx.doi.org/10.1016/j.nmni.2020.100680
work_keys_str_mv AT saqranes reviewontheglobalepidemiologicalsituationandtheefficacyofchloroquineandhydroxychloroquineforthetreatmentofcovid19
AT elmhammedima reviewontheglobalepidemiologicalsituationandtheefficacyofchloroquineandhydroxychloroquineforthetreatmentofcovid19